The Bank of N.T. Butterfield & Son Limited (NTB) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 3.67%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 3.67% | Share-based compensation / revenue. Period ending 2025-12-31. $22.25M ÷ $606.79M × 100 ≈ 3.67% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 606.79M USD | |
| Stock-based compensation | 22.25M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | (m) | $606.79M | $22.25M | (m) | (m) | (m) | 3.67% | (m) | (m) |
| 2024-12-31 | (m) | $579.93M | $21.00M | (m) | (m) | (m) | 3.62% | (m) | (m) |
| 2023-12-31 | (m) | $578.60M | $20.81M | (m) | $178.67M | (m) | 3.60% | (m) | Reported |
| 2022-12-31 | (m) | $549.30M | $17.08M | (m) | $54.80M | (m) | 3.11% | (m) | Reported |
| 2021-12-31 | (m) | $499.68M | $15.15M | (m) | $25.09M | (m) | 3.03% | (m) | Reported |
| 2020-12-31 | (m) | $494.19M | $15.24M | (m) | $34.41M | (m) | 3.08% | (m) | Reported |
| 2019-12-31 | (m) | $532.63M | $17.72M | (m) | $59.38M | (m) | 3.33% | (m) | Reported |
| 2018-12-31 | (m) | $517.81M | $12.58M | (m) | $24.60M | (m) | 2.43% | (m) | Reported |
| 2017-12-31 | (m) | (m) | $8.41M | (m) | $15.88M | (m) | (m) | (m) | Reported |
| 2016-12-31 | (m) | (m) | $14.42M | (m) | $16.45M | (m) | (m) | (m) | Reported |
| 2015-12-31 | (m) | (m) | $7.91M | (m) | $23.32M | (m) | (m) | (m) | Reported |
| 2014-12-31 | (m) | (m) | $9.05M | (m) | $26.61M | (m) | (m) | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.